Skip to content

MapTrek for Sedentary Workers

MapTrek for Sedentary Workers

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03109535
Enrollment
146
Registered
2017-04-12
Start date
2016-09-01
Completion date
2017-04-01
Last updated
2017-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sedentary Lifestyle

Brief summary

The aim of this study is to determine if participants randomized to our mHealth MapTrek game increases daily physical activity (average steps/day, active minutes/day) compared to a control group among sedentary office workers over 10 weeks. The investigators hypothesize the MapTrek intervention group will significantly increase their daily steps and active minutes compared to the control group over 10 weeks.

Interventions

BEHAVIORALFitbit + Maptrek

Users receive a Fitbit Zip to wear daily. Users aslo receive the mHealth MapTrek game that places users in weekly walking races and sends automated text messages to users on a daily basis for the purpose of increasing daily physical activity.

BEHAVIORALFitbit only

Users receive a Fitbit Zip to wear daily.

Sponsors

University of Iowa
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Eligible participants were 21 to 65 year of age, working full-time (at least 35 hours/week) in a desk-dependent job (self-report sitting \>75% of work day), who owned a smart phone.

Exclusion criteria

*

Design outcomes

Primary

MeasureTime frameDescription
Average daily steps10 weeksTotal daily steps as recorded by the Fitbit Zip

Secondary

MeasureTime frameDescription
Average daily active minutes10 weeksMinutes with at least 100 steps/minute as recorded by the Fitbit Zip

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 6, 2026